Hospital Nacional Cayetano Heredia

Lima LIMA 31

1 studies enrolling now · 14 studies all time

What they study most

Active Idiopathic Inflammatory Myopathy, Amyotrophic Lateral Sclerosis, Antisynthetase Syndrome, Arthritis, Rheumatoid, COVID-19 Pneumonia, Dermatomyositis, HIV Infections, Immune-Mediated Necrotizing Myopathy, Lupus, Lupus Erythematosus, Systemic, Lupus Nephritis, Metastatic Renal Cell Carcinoma

Studies at this site

• Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus — Enrolling by invitation
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — Completed
• A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome — Running, not enrolling
• A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132) — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early
• A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia — Completed
• Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care — Completed
• A Phase II Study of M2951 in SLE — Stopped early
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis — Completed
• Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
• Management of Myocardial Injury After Noncardiac Surgery Trial — Completed
• Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection — Stopped early